메뉴 건너뛰기




Volumn 16, Issue 8, 2014, Pages 1048-1056

Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model

Author keywords

GIC; Glioma stem cell; Glioma initiating cell; Metabolism; Warburg effect

Indexed keywords

GLUCOSE; GLYCOLYTIC ENZYME; HEXOKINASE 2; LACTIC ACID; NUCLEOSIDE; OLIGOMYCIN; OXYGEN; PHOSPHOTRANSFERASE; PYRUVATE KINASE; UNCLASSIFIED DRUG;

EID: 84904335873     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou096     Document Type: Article
Times cited : (44)

References (27)
  • 1
    • 12444279265 scopus 로고
    • On the origin of cancer cells
    • Warburg O. On the origin of cancer cells. Science. 1956;123(3191): 309-314
    • (1956) Science , vol.123 , Issue.3191 , pp. 309-314
    • Warburg, O.1
  • 2
    • 0033079597 scopus 로고    scopus 로고
    • Oncogenic alterations of metabolism
    • DOI 10.1016/S0968-0004(98)01344-9, PII S0968000498013449
    • Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci. 1999;24(2):68-72 (Pubitemid 29346576)
    • (1999) Trends in Biochemical Sciences , vol.24 , Issue.2 , pp. 68-72
    • Dang, C.V.1    Semenza, G.L.2
  • 4
    • 84865976786 scopus 로고    scopus 로고
    • Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review
    • doi:10.3389/fphar.2011.00049
    • Porporato PE, Dhup S, Dadhich RK, et al. Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review. Front Pharmacol. 2011;2:49. doi:10.3389/fphar.2011.00049
    • (2011) Front Pharmacol , vol.2 , pp. 49
    • Porporato, P.E.1    Dhup, S.2    Dadhich, R.K.3
  • 5
    • 77954924659 scopus 로고    scopus 로고
    • Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma
    • Stupp R, Hegi ME, Neyns B, et al. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. J ClinOncol. 2010;28(16):2712-2718
    • (2010) J ClinOncol , vol.28 , Issue.16 , pp. 2712-2718
    • Stupp, R.1    Hegi, M.E.2    Neyns, B.3
  • 6
    • 77951599543 scopus 로고    scopus 로고
    • Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma
    • Huse JT, Holland EC. Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 2010;10(5):319-331
    • (2010) Nat Rev Cancer , vol.10 , Issue.5 , pp. 319-331
    • Huse, J.T.1    Holland, E.C.2
  • 7
    • 80052714649 scopus 로고    scopus 로고
    • Molecular imaging of gliomas with PET: Opportunities and limitations
    • la Fougere C, Suchorska B, Bartenstein P, et al. Molecular imaging of gliomas with PET: Opportunities and limitations. Neuro Oncol. 2011; 13(8):806-819
    • (2011) Neuro Oncol , vol.13 , Issue.8 , pp. 806-819
    • La Fougere, C.1    Suchorska, B.2    Bartenstein, P.3
  • 8
    • 48949116219 scopus 로고    scopus 로고
    • Proton MR spectroscopy of cerebral gliomas at 3 T: Spatial heterogeneity, and tumour grade and extent
    • Di Costanzo A, Scarabino T, Trojsi F, et al. Proton MR spectroscopy of cerebral gliomas at 3 T: Spatial heterogeneity, and tumour grade and extent. Eur Radiol. 2008;18(8):1727-1735
    • (2008) Eur Radiol , vol.18 , Issue.8 , pp. 1727-1735
    • Di Costanzo, A.1    Scarabino, T.2    Trojsi, F.3
  • 9
    • 77952995998 scopus 로고    scopus 로고
    • Metabolicmodulation of glioblastoma with dichloroacetate
    • Michelakis ED, Sutendra G, Dromparis P, et al. Metabolicmodulation of glioblastoma with dichloroacetate. Sci Transl Med. 2010;2(31):31ra34
    • (2010) Sci Transl Med , vol.2 , Issue.31 , pp. 31-34
    • Michelakis, E.D.1    Sutendra, G.2    Dromparis, P.3
  • 10
    • 84875753357 scopus 로고    scopus 로고
    • Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized 13)C magnetic resonance spectroscopic imaging
    • Park JM, Recht LD, Josan S, et al. Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. Neuro Oncol. 2013; 15(4):433-441
    • (2013) Neuro Oncol , vol.15 , Issue.4 , pp. 433-441
    • Park, J.M.1    Recht, L.D.2    Josan, S.3
  • 12
    • 84862016091 scopus 로고    scopus 로고
    • Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo
    • Marin-Valencia I, Yang C, Mashimo T, et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab. 2012;15(6):827-837
    • (2012) Cell Metab , vol.15 , Issue.6 , pp. 827-837
    • Marin-Valencia, I.1    Yang, C.2    Mashimo, T.3
  • 13
    • 80053166769 scopus 로고    scopus 로고
    • Metabolic state of glioma stem cells and nontumorigenic cells
    • Vlashi E, Lagadec C, Vergnes L, et al. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A. 2011; 108(38):16062-16067
    • (2011) Proc Natl Acad Sci U S A. , vol.108 , Issue.38 , pp. 16062-16067
    • Vlashi, E.1    Lagadec, C.2    Vergnes, L.3
  • 14
    • 73649123907 scopus 로고    scopus 로고
    • Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
    • Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98-110
    • (2010) Cancer Cell , vol.17 , Issue.1 , pp. 98-110
    • Verhaak, R.G.1    Hoadley, K.A.2    Purdom, E.3
  • 15
    • 26944452745 scopus 로고    scopus 로고
    • Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines
    • DOI 10.1007/s11060-004-6404-6
    • Griguer CE, Oliva CR, Gillespie GY. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines. J Neurooncol. 2005;74(2):123-133 (Pubitemid 41478907)
    • (2005) Journal of Neuro-Oncology , vol.74 , Issue.2 , pp. 123-133
    • Griguer, C.E.1    Oliva, C.R.2    Gillespie, G.Y.3
  • 16
    • 80053452975 scopus 로고    scopus 로고
    • Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells
    • Sampetrean O, Saga I, Nakanishi M, et al. Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia. 2011;13(9):784-791
    • (2011) Neoplasia , vol.13 , Issue.9 , pp. 784-791
    • Sampetrean, O.1    Saga, I.2    Nakanishi, M.3
  • 17
    • 84875767442 scopus 로고    scopus 로고
    • IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells
    • Osuka S, Sampetrean O, Shimizu T, et al. IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells. Stem Cells. 2013;31(4):627-640
    • (2013) Stem Cells , vol.31 , Issue.4 , pp. 627-640
    • Osuka, S.1    Sampetrean, O.2    Shimizu, T.3
  • 18
    • 77953888141 scopus 로고    scopus 로고
    • Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry
    • Urakami K, Zangiacomi V, Yamaguchi K, et al. Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry. Biomed Res. 2010;31(2):161-163
    • (2010) Biomed Res , vol.31 , Issue.2 , pp. 161-163
    • Urakami, K.1    Zangiacomi, V.2    Yamaguchi, K.3
  • 19
    • 37449024702 scopus 로고    scopus 로고
    • The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
    • DeBerardinis RJ, LumJJ, Hatzivassiliou G, et al. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11-20
    • (2008) Cell Metab , vol.7 , Issue.1 , pp. 11-20
    • De Berardinis, R.J.1    Lum, J.J.2    Hatzivassiliou, G.3
  • 20
    • 80053916176 scopus 로고    scopus 로고
    • Metabolic regulation of hematopoietic stem cells in the hypoxic niche
    • Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell. 2011;9(4):298-310
    • (2011) Cell Stem Cell , vol.9 , Issue.4 , pp. 298-310
    • Suda, T.1    Takubo, K.2    Semenza, G.L.3
  • 21
    • 84872011926 scopus 로고    scopus 로고
    • Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells
    • Takubo K, Nagamatsu G, Kobayashi CI, et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell. 2013;12(1):49-61
    • (2013) Cell Stem Cell , vol.12 , Issue.1 , pp. 49-61
    • Takubo, K.1    Nagamatsu, G.2    Kobayashi, C.I.3
  • 22
    • 84868351585 scopus 로고    scopus 로고
    • Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal
    • Zhang J, Nuebel E, Daley GQ, et al. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell. 2012;11(5):589-595
    • (2012) Cell Stem Cell , vol.11 , Issue.5 , pp. 589-595
    • Zhang, J.1    Nuebel, E.2    Daley, G.Q.3
  • 24
    • 35649014840 scopus 로고    scopus 로고
    • Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
    • DOI 10.1128/MCB.00440-07
    • Kim JW, Gao P, Liu YC, et al. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol. 2007;27(21):7381-7393 (Pubitemid 350033646)
    • (2007) Molecular and Cellular Biology , vol.27 , Issue.21 , pp. 7381-7393
    • Kim, J.-W.1    Gao, P.2    Liu, Y.-C.3    Semenza, G.L.4    Dang, C.V.5
  • 25
    • 37549032776 scopus 로고    scopus 로고
    • The interplay between MYC and HIF in cancer
    • Dang CV, Kim JW, Gao P, et al. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008;8(1):51-56
    • (2008) Nat Rev Cancer , vol.8 , Issue.1 , pp. 51-56
    • Dang, C.V.1    Kim, J.W.2    Gao, P.3
  • 26
    • 56849131763 scopus 로고    scopus 로고
    • C-Myc is required for maintenance of glioma cancer stem cells
    • Wang J, Wang H, Li Z, et al. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One. 2008;3(11):e3769
    • (2008) PLoS One , vol.3 , Issue.11
    • Wang, J.1    Wang, H.2    Li, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.